Ozempic
- Product NDC
- 50090-5139
- 11-digit product format
- 500905139
- Labeler code
- 50090
- Product ID
- 50090-5139_c4869820-1a83-42b5-8ba0-46fa98e373fd
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- semaglutide
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Labeler
- A-S Medication Solutions
- Application
- NDA209637
- Marketing category
- NDA
- Marketing start
- 2017-12-06
- Marketing end
- 0000-00-00
- Substance
- SEMAGLUTIDE
- Active strength
- 1 mg/mL
- Pharmacologic classes
- GLP-1 Receptor Agonist [EPC],Glucagon-Like Peptide 1 [CS],Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50090-5139-0 | Ozempic | 2 in 1 CARTON | INJECTION, SOLUTION | 2 | | 1 |
| 50090-5139-0 | Ozempic | 1.5 mL in 1 SYRINGE, PLASTIC | INJECTION, SOLUTION | 1.5 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50090-5139 | OZEMPIC (SEMAGLUTIDE) INJECTION, SOLUTION [A-S MEDICATION SOLUTIONS] | 1 | Legacy NDC, 2 package rows | 20210115_35902e95-e00c-47ae-8f4e-ba17d41881ce.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-5139-0 | 50090513900 | 2 SYRINGE, PLASTIC in 1 CARTON (50090-5139-0) > 1.5 mL in 1 SYRINGE, PLASTIC | 2020-08-31 | 0000-00-00 | No | No | Current |